Stock futures were higher Thursday premarket as investors digested Wednesday’s strong U.S. jobs report while eyeing fresh corporate earnings and upcoming inflation data.
Here are some of Thursday’s biggest stock movers:
Biggest stock gainers
- Fastly (FSLY) +34% – Shares surged after the content delivery network provider delivered a strong Q4 beat and issued guidance that significantly topped expectations. For Q1, Fastly expects adjusted EPS of $0.07–$0.10 vs. the $0.01 consensus, while revenue is guided at $168M–$174M, comfortably above the $159.6M estimate. Strength carried into the full-year outlook, with adjusted EPS projected at $0.23–$0.29 vs. $0.13 consensus and revenue of $700M–$720M, well ahead of the ~$668M forecast, signaling improving profitability and stronger demand momentum.
- Novocure (NVCR) +31% – Shares soared after the FDA approved Optune Pax for adults with locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel. Approval was backed by the Phase 3 PANOVA-3 trial, which showed a statistically significant overall survival benefit, extending median OS by ~2 months in the intent-to-treat population and over 3 months in treated patients, without added systemic toxicity. The therapy also delayed pain progression and improved quality-of-life measures, marking the first major treatment advance in decades for this patient group.
Biggest stock losers
- QuantumScape (QS) -9% – Shares slid after its latest quarterly results showed no revenue from its core business and a lack of FY2026 revenue guidance or new OEM partnerships, despite a modest profit beat. The company plans to step up investment in scaling its solid-state battery via the Eagle Line, lifting 2026 capex to $40M–$60M from $36.3M in 2025, while offering only broad commercialization goals. Although a 14% cut in operating expenses narrowed the loss to $0.17 per share (slightly better than expected), investors were weighed down by the absence of near-term revenue visibility, with inaugural customer billings totaling $19.5M in 2025.
- Cisco Systems (CSCO) -8% – Shares slipped despite delivering FQ2 results and guidance above expectations, as investors focused on broader demand concerns. For FQ3, Cisco guided sales of $15.4B–$15.6B and adjusted EPS of $1.02–$1.04, both ahead of consensus, with gross margins seen at 65.5%–66.5%. Full-year guidance also topped estimates, with adjusted EPS of $4.13–$4.17 vs. the consensus of $4.13 and revenue of $61.2B–$61.7B vs. the consensus of $60.76B.
- AppLovin (APP) -6% – Shares fell even though the company reported a strong Q4 beat. The company reported GAAP EPS of $3.24 vs. $2.94 expected, while revenue surged 66% Y/Y to $1.66B, topping consensus. The company expects Q1 2026 revenue at $1.745B–$1.775B, well above estimates of $1.7B. It also highlighted aggressive capital returns, repurchasing $481M of stock in Q4 and $2.58B in 2025.